Copyright 2017 American Medical Association. All Rights Reserved.
To the Editor The various pathologies comprising sudden unexpected death are of considerable clinical priority, the etiologies of which may be amenable to interrogation by sequencing approaches. As pointed out by Dr Torkamani and colleagues,1 identifying causal genetic variants by postmortem genetic testing affects family members and may suggest treatments for similar carriers. Clinical genetic testing using next-generation sequencing technologies has spurred advances in the molecular diagnosis of numerous rare diseases.
Schrodi SJ. Postmortem Genetic Testing for Sudden Unexpected Death. JAMA. 2017;317(3):320–321. doi:10.1001/jama.2016.19271
Customize your JAMA Network experience by selecting one or more topics from the list below.